weight loss drug semaglutide Pill form of popular drugs could be on the way Semaglutide GLP-1 Injections for Medical

Short Half-Life: Rapid enzymatic degradation on the skin surface reduces the therapeutic window

E61.1 captures the first two stages

Summary Takeaway Messages Despite the ability of GLP-1s to produce significant weight reduction and related health benefits, challenges such as GI side effects, risk of nutrient inadequacies, loss of muscle and bone mass, high costs, frequent discontinuation, and weight regain limit the use of these drugs for long-term success in individuals and populations

Quantification and statistical analysis Qualitative data were shown as frequency with percentage, while quantitative data were shown as median with interquartile range

Ozempic uses the active ingredient semaglutide, and Wegovy is the version approved for weight loss